Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cancer cells

British Journal of Cancer

Volumn 77, Issue 9, 1998, Pages 1378-1385

  Zaffaroni, N ^a   Silvestrini, R ^a   Orlandi, L ^a   Bearzatto, A ^a   Gornati, D ^a   Villa, R ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Apoptosis; Cell cycle related proteins; Cisplatin; Ovarian cancer; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; DNA FRAGMENT; PACLITAXEL; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE S PHASE; CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0031920710     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.230     Document Type: Article

References (35)

1. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutzen T, McKoy WM, Young RC and Ozols RF (1987) Characterization of a cis-diamininedichloroplatinum (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47: 414-418
2. waf1 and p53 requires c-raf-1. Cancer Res 55: 4623-4626
3. Chou TC and Talalay P (1986) Quantitative analysis of dose-effect relationship: the combined effect of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55
4. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ (1995) A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356
5. Danesi R, Figg WD, Reed E and Myers CE (1995) Paclitaxel (Taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Molec Pharmacol 47: 1106-1111
6. cdc2 coincident with taxol-induced apoptosis. Cell Growth Diff 5: 1041-1050
7. Finzig AI, Wiernik PH, Sasloff J, Runowicz CD and Goldberg GL (1992) Phase II study and long-term follow-up of patients treated with paclitaxel for advanced ovarian adenocarcinoma. J Clin Oncol 10: 1748-1753
8. El-Deiry WS, Tokino T, Veculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p.53 tumor suppression. Cell 75: 817-825
9. 1 arrest and apoptosis. Cancer Res 54: 1169-1174
10. Fritsche M, Haessler C and Brandner G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307-318
11. Haldar S, Chintapalli J and Croce CM (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255
12. Jekunen AP, Christen RD, Shalinsky DR and Howell SB (1994) Synergistic interaction between cisplatin and Taxol in human ovarian carcinoma cells in vitro. Br J Cancer 69: 294-306
13. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig R (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311
14. Kelland LR and Abel G (1992) Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin sensitive and resistant human ovarian cancer cell lines. Cancer Chemother Pharmacol 30: 444-450
15. Legha SS, Ring S, Papadopoulos N, Raber M and Benjamin RA (1990) Phase II study of taxol in metastatic melanoma. Cancer 65: 2478-2481
16. Lewin B (1990) Driving the cell cycle: M phase kinase, its partners, and substrates. Cell 61: 743-752
17. 1.1) combined with eisplatin or alkylators in human cancer cells. Oncol Res 6: 25-31
18. Ling YH, Priebe W and Perez-Soler R (1993) Apoptosis induced by anthracycline in P388 parent and multidrug-resistant cells. Cancer Res 53: 1845-1852
19. Liu Y, Bhalla K, Hill C and Priest DG (1994) Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line. Biochem Pharmacol 48: 1265-1272
20. Maltzman W and Czyzyk L (1944) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689-1694
21. Milross CG, Pelers LJ, Hunter NR, Mason KA and Milas L (1995) Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo. Int J Cancer 62: 599-604
22. Mohith A, Photiou A and Retsas S (1996) The combination of paclitaxel with cisplatin exhibits antagonism in vitro against human melanoma. Anti-cancer Drug 7: 493-498
23. Nabholts JM, Gelmon M and Bontenbal M (1993) Randomized trial of two doses of paclitaxel in metastatic breast cancer: an interim analysis. Proc Am Soc Clin Oncol 12: 42
24. Nelson WG and Kastan MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14: 1815-1823
25. Nishio K, Arioka H, Ishida T, Fukumoto H, Kurokawa H, Sata M, Ohata W and Saijo N (1995) Enhanced interaction between tubulin and microtubule-associated protein 2 via inhibition of map kinase and edc2 kinase by paclitaxel. Int J Cancer 63: 688-693
26. Nurse P (1990) Universal control mechanism regulating onset of M-phase. Nature 344: 503-508
27. cdc2 activation required for apoptosis. Science 263: 1143-1145
28. Shimizu T, O'Connor PM, Kohn KW and Pommier Y (1995) Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res 55: 228-231
29. Silvestrini R, Zaffaroni N, Orlandi L and Orlana S (1993) In vitro cytotoxic activity of Taxol® and Taxotere on primary cultures and established cell lines of human ovarian cancer. Stem Cells 11: 528-535
30. Solomon MJ (1993) Activation of the various cyclin/edc2 protein kinases. Curr Opin Cell Biol 5: 180-186
31. 2 arrest and DNA double strand breaks. Cancer Res 48: 4484-4488
32. Tishler RB, Schiff PB, Geard CR and Hall EJ (1992) Taxol: a novel radiation sensitizer. Int J Rad Oncol Biol Phys 22: 613-617
33. Tishler RB, Lamppu DM, Park S and Price BD (1995) Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res 55: 6021-6025
34. Waga S, Hannon GJ, Beach D and Stillman B (1994) The p21 inhibitor of cyclin dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578
35. 2/M arrest and upoptosis. Nature Med 2: 72-79